Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05182190 · ClinicalTrials.gov registry record · NA

Effects of Black Bean Pasta Consumption on Biomarkers in Young Adults

A NA study, sponsored by Iowa State University.

Completed
Registry status
NA
Development phase
18
Enrollment target

NCT05182190: Completed NA study, sponsored by Iowa State University.

NCT05182190 is a NA study that has completed, run by Iowa State University. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05182190, a NA study, has completed, sponsored by Iowa State University.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

The study purpose is to determine the effect of eating three (3) different pasta flour formulations made from 100% black beans (Zenith) in a meal matrix (spaghetti sauce) on postprandial glycemic response in healthy adults.

Primary Outcome

Venous blood samples were collected via venous catheter. Whole blood samples were analyzed for glucose content and insulin at commercial laboratory.

Interventions

  • DIETARY_SUPPLEMENT White bread
  • DIETARY_SUPPLEMENT Black beans whole boiled
  • DIETARY_SUPPLEMENT Knife Mill pasta
  • DIETARY_SUPPLEMENT Combo Flour Pasta
  • DIETARY_SUPPLEMENT Cyclone Flour Pasta

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2019-07-10
Est. Completion 2020-03-15
Phase NA
Iowa State University

23 total trials

What the finished NCT05182190 record still lists

NCT05182190 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 5 interventions - of which White bread is the first listed.

NCT05182190 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05182190 about?

NCT05182190 is a clinical study titled "Effects of Black Bean Pasta Consumption on Biomarkers in Young Adults". The study purpose is to determine the effect of eating three (3) different pasta flour formulations made from 100% black beans (Zenith) in a meal matrix (spaghetti sauce) on postprandial glycemic response in healthy adults.

What is the current status of trial NCT05182190?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2019-07-10. Estimated completion is 2020-03-15.

What interventions are being tested in trial NCT05182190?

The interventions under investigation include: White bread (DIETARY_SUPPLEMENT), Black beans whole boiled (DIETARY_SUPPLEMENT), Knife Mill pasta (DIETARY_SUPPLEMENT), Combo Flour Pasta (DIETARY_SUPPLEMENT), Cyclone Flour Pasta (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05182190?

This trial is sponsored by Iowa State University, which has 23 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05182190's enrollment target sits among peer trials

18 1863rd of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05182190, the US trial registry maintained by the National Library of Medicine. NCT05182190 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.